Simon X. Benito - 20 Jul 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Simon X. Benito
Issuer symbol
INO
Transactions as of
20 Jul 2022
Net transactions value
-$100
Form type
4
Filing time
20 Jul 2022, 16:16:37 UTC
Previous filing
17 May 2022
Next filing
16 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise $4,400 +2,000 +2.7% $2.20 77,305 20 Jul 2022 Direct
transaction INO Common Stock Sale $4,500 -2,000 -2.6% $2.25 75,305 20 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Common Stock Options Options Exercise $0 -2,000 -33% $0.000000 4,000 20 Jul 2022 Common Stock 2,000 $2.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.